Social Media Ideas for India Pharma

IPCA Labs, Biocon, Laurus Labs, Gland Pharma, Aurobindo, Sun Pharma shares hit 52-week highs; what's next?

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, JB Chemicals & Pharmaceuticals Ltd, Manki...

5 Indian CDMO Stocks Benefiting from the Global Pharma Outsourcing Boom

Synopsis: Global pharmaceutical companies are rapidly diversifying their manufacturing supply chains as geopolitical tensions, regulatory changes and the proposed U.S. BIOSECURE Ac...

India willing to open market to high-quality, innovative pharma products: Goyal

He projected that India’s pharmaceutical market could grow to USD 120 billion within five years, up from about USD 60 billion currently

Pharma industry body scouts for Indian suppliers as US faces cancer drug shortage

 Industry body reaches out to members for information on ifosfamide manufacturing capacity amid shortage in the United States

Sun Pharma to acquire Innovcare Lifesciences in ₹271 crore deal

Pharma: Can India take advantage of a China+1 opportunity

India–Oman Pact Strengthens Pharmaceutical Trade And Healthcare Cooperation

The India–Oman Comprehensive Economic Partnership Agreement (CEPA) has created unprecedented opportunities for Indian pharmaceutical exporters by granting zero‑duty access, fast‑tr...

How Indian Pharma Companies Are Strengthening Domestic Healthcare Access Post-Pandemic

The COVID-19 pandemic highlighted the importance of resilient healthcare systems, reliable medicine supply chains, and accessible healthcare solutions. While the immediate healthca...

Pharma Stock Jumps After Securing ₹515 Cr Contracts from Malaysia’s Ministry of Health

Synopsis: Biocon strengthened its Malaysia presence after partner Duopharma secured insulin contracts worth over ₹514 crore, supporting affordable diabetes treatment and expanding...

Chennai: For All FTA Talks, There Should Be A Model Pharma Chapter: Niti Aayog

The Mission Biopharma SHAKTI scheme, launched in 2026-27, marks an important step in promoting biologics and biosimilars manufacturing: Reports

India’s Pharma Supply Chain Still 65% Dependent on Chinese Imports: NITI Aayog

Releasing the report, Niti Aayog vice chairman Ashok Kumar Lahiri said India is considered the pharmacy of the world.

Pharma Stocks Rally Far From Over? Expert Sees New Growth Era For Indian Drugmakers Amid Global Expansion

Indian pharma companies may be entering a new phase of growth rather than nearing the end of their rally. Market expert Nishchal Maheshwari believes the sector is witnessing a stru...

Here's how this Indian company's antibiotic became the first to receive US FDA

Wockhardt is betting big on a space the world's largest pharmaceutical companies have abandoned.

CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation

CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation

When ‘Made in India’ really means ‘Made in China’

India’s pharmaceutical industry is a significant global player. It produces about 20% of the world’s generic drugs by volume and has supported major vaccine efforts, providing affo...

India’s Pharma Supply Chain Heavily Reliant on Chinese Imports: NITI Aayog

The report pointed out that weak innovation and a commercialisation ecosystem have created uncertainty for innovators and long-term investments.

20% Upper Circuit: Pharma Stock Skyrockets After Announcing Strong Q4 Earnings

Synopsis: The share of this pharma company hit a 20 percent upper circuit after strong Q4 FY26 earnings driven by anesthetic demand, robust margins, and export-led growth momentum....

Gland Pharma, Sun Pharmaceutical, Laurus Labs shares zoom up to 16% to hit 52-week highs; here's why

Gland Pharma jumped 15.85 per cent to Rs 2,164.40, while Sun Pharma climbed 1 per cent to Rs 1,896.90. Laurus Labs moved up 0.63 per cent to Rs 1,332.

Ipca inks licensing agreement with Bhami Research for biologics delivery platform access

Licencing agreement grants Ipca access to Bhami Research’s proprietary high-concentration subcutaneous biologics delivery platform for the development and commercialisation of mult...

6 Pharma Stocks That Delivered Returns of Up to 225% in Just 6 Months; Do You Hold Any?

Synopsis: Pharma stocks surged as Bliss GVS Pharma, Kwality Pharma, Aptus Pharma, Venus Remedies, Rubicon Research, and Ind-Swift Laboratories delivered over 100% returns in six mo...

US Turn To Indian Pharmaceuticals Amid Critical Cancer Drug Shortage

US has sought help from Indian pharmaceutical manufacturers to address a shortage of the cancer drug ifosfamide.

Nifty Pharma hits record high; Divi's Labs, Torrent Pharma, Sun Pharma shares shine 

Powered by a rally in the pharma stocks, Nifty pharma index hit a record high of 26,103 in the current session. The index has rallied 17% or 3786 points in six months. 

IPC signs MoU with UP Promote Pharma Council to strengthen quality standards

The MoU comes as Uttar Pradesh seeks to expand investments in pharmaceuticals and medical technology through industrial clusters and manufacturing infrastructure.

Post-pandemic shift sees pharma firms expand focus on healthcare access

The COVID-19 pandemic may have subsided, but its impact continues to influence India's healthcare landscape, driving pharmaceutical companies to expand their role beyond medicine m...